Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension

References

• ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA200228829819712479763
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationTreatment of hypertension in adults with diabetesDiabetes Care20022519920111772916
   PubMed Web of Science ®Google Scholar
• BakrisGLA practical approach to achieving recommended blood pressure goals in diabetic patientsArch Intern Med20011612661711732930
   PubMedGoogle Scholar
• BensonKHartzAJA comparison of observational studies and randomized, controlled trialsAm J Ophthalmol200013068811078861
   PubMedGoogle Scholar
• BisognanoJMcLaughlinTRobertsCSIncremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimensAm J Hypertens2004176768315323063
   PubMed Web of Science ®Google Scholar
• BlackHRElliottWJGranditsGPrincipal results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trialJAMA200328920738212709465
   PubMed Web of Science ®Google Scholar
• BurnierMSchneiderMPChioleroAElectronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisionsJ Hypertens2001193354111212978
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis198740373833558716
   PubMedGoogle Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034212065214656957
   PubMed Web of Science ®Google Scholar
• ConcatoJShahNHorwitzRIRandomized, controlled trials, observational studies, and the hierarchy of research designsN Engl J Med200034218879210861325
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBJrPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med1998172265819802183
   PubMed Web of Science ®Google Scholar
• DahlöfBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DahlöfBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• Guidelines CommitteeEuropean Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• HajjarIKotchenTATrends in prevalence, awareness, treatment, and control of hypertension in the United States 1988–2000JAMA200329019920612851274
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983511755629635947
   PubMed Web of Science ®Google Scholar
• IzzoJLJrLevyDBlackHRClinical Advisory Statement. Importance of systolic blood pressure in older AmericansHypertension2000351021410818056
   PubMedGoogle Scholar
• Joint National Committee on, Detection, Evaluation, and Treatment of High Blood PressureThe Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArch Intern Med19971572413469385294
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436320223115207952
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013458516011565517
   PubMed Web of Science ®Google Scholar
• MatersonBJRedaDJCushmanWCSingle-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsN Engl J Med1993328914218446138
   PubMed Web of Science ®Google Scholar
• MonaneMBohnRLGurwitzJHThe effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderlyAm J Hypertens1997106977049234822
   PubMed Web of Science ®Google Scholar
• PetriHUrquhartJChanneling bias in the interpretation of drug effectsStat Med199110577812057656
   PubMed Web of Science ®Google Scholar
• RomanoPSRoosLLJollisJGAdapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectivesJ Clin Epidemiol1993461075978410092
   PubMed Web of Science ®Google Scholar
• StaessenJAWangJGThijsLCardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003J Hypertens20032110557612777939
   PubMed Web of Science ®Google Scholar
• TurnbullFNealBAlgertCEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med200516514101915983291
   PubMed Web of Science ®Google Scholar